273 related articles for article (PubMed ID: 19591808)
21. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.
Miyamoto S; Duncan GE; Marx CE; Lieberman JA
Mol Psychiatry; 2005 Jan; 10(1):79-104. PubMed ID: 15289815
[TBL] [Abstract][Full Text] [Related]
22. Messing up with traffic: different effects of antipsychotic agents on glutamate receptor complexes in vivo.
Del'guidice T; Beaulieu JM
Mol Pharmacol; 2008 May; 73(5):1339-42. PubMed ID: 18314495
[TBL] [Abstract][Full Text] [Related]
23. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia.
Shinkai T; De Luca V; Hwang R; Müller DJ; Lanktree M; Zai G; Shaikh S; Wong G; Sicard T; Potapova N; Trakalo J; King N; Matsumoto C; Hori H; Wong AH; Ohmori O; Macciardi F; Nakamura J; Kennedy JL
Neuromolecular Med; 2007; 9(2):169-77. PubMed ID: 17627036
[TBL] [Abstract][Full Text] [Related]
24. The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.
Sparey T; Abeywickrema P; Almond S; Brandon N; Byrne N; Campbell A; Hutson PH; Jacobson M; Jones B; Munshi S; Pascarella D; Pike A; Prasad GS; Sachs N; Sakatis M; Sardana V; Venkatraman S; Young MB
Bioorg Med Chem Lett; 2008 Jun; 18(11):3386-91. PubMed ID: 18455394
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.
Laruelle M; Frankle WG; Narendran R; Kegeles LS; Abi-Dargham A
Clin Ther; 2005; 27 Suppl A():S16-24. PubMed ID: 16198197
[TBL] [Abstract][Full Text] [Related]
26. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.
Labrie V; Clapcote SJ; Roder JC
Pharmacol Biochem Behav; 2009 Feb; 91(4):610-20. PubMed ID: 18940194
[TBL] [Abstract][Full Text] [Related]
27. Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect.
Rojas C; Alt J; Ator NA; Wilmoth H; Rais R; Hin N; DeVivo M; Popiolek M; Tsukamoto T; Slusher BS
J Psychopharmacol; 2016 Sep; 30(9):887-95. PubMed ID: 27287825
[TBL] [Abstract][Full Text] [Related]
28. No association of G72 and D-amino acid oxidase genes with schizophrenia.
Liu YL; Fann CS; Liu CM; Chang CC; Wu JY; Hung SI; Liu SK; Hsieh MH; Hwang TJ; Chan HY; Chen JJ; Faraone SV; Tsuang MT; Chen WJ; Hwu HG
Schizophr Res; 2006 Oct; 87(1-3):15-20. PubMed ID: 16842973
[TBL] [Abstract][Full Text] [Related]
29. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.
Chumakov I; Blumenfeld M; Guerassimenko O; Cavarec L; Palicio M; Abderrahim H; Bougueleret L; Barry C; Tanaka H; La Rosa P; Puech A; Tahri N; Cohen-Akenine A; Delabrosse S; Lissarrague S; Picard FP; Maurice K; Essioux L; Millasseau P; Grel P; Debailleul V; Simon AM; Caterina D; Dufaure I; Malekzadeh K; Belova M; Luan JJ; Bouillot M; Sambucy JL; Primas G; Saumier M; Boubkiri N; Martin-Saumier S; Nasroune M; Peixoto H; Delaye A; Pinchot V; Bastucci M; Guillou S; Chevillon M; Sainz-Fuertes R; Meguenni S; Aurich-Costa J; Cherif D; Gimalac A; Van Duijn C; Gauvreau D; Ouellette G; Fortier I; Raelson J; Sherbatich T; Riazanskaia N; Rogaev E; Raeymaekers P; Aerssens J; Konings F; Luyten W; Macciardi F; Sham PC; Straub RE; Weinberger DR; Cohen N; Cohen D
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13675-80. PubMed ID: 12364586
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
Katane M; Osaka N; Matsuda S; Maeda K; Kawata T; Saitoh Y; Sekine M; Furuchi T; Doi I; Hirono S; Homma H
J Med Chem; 2013 Mar; 56(5):1894-907. PubMed ID: 23391306
[TBL] [Abstract][Full Text] [Related]
31. D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.
Sacchi S; Rosini E; Pollegioni L; Molla G
Curr Pharm Des; 2013; 19(14):2499-511. PubMed ID: 23116391
[TBL] [Abstract][Full Text] [Related]
32. Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophrenia.
Ohnuma T; Arai H
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):29-39. PubMed ID: 20828596
[TBL] [Abstract][Full Text] [Related]
33. Antipsychotic drug action: targets for drug discovery with neurochemical imaging.
Stone JM; Pilowsky LS
Expert Rev Neurother; 2006 Jan; 6(1):57-64. PubMed ID: 16466312
[TBL] [Abstract][Full Text] [Related]
34. Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.
Duplantier AJ; Becker SL; Bohanon MJ; Borzilleri KA; Chrunyk BA; Downs JT; Hu LY; El-Kattan A; James LC; Liu S; Lu J; Maklad N; Mansour MN; Mente S; Piotrowski MA; Sakya SM; Sheehan S; Steyn SJ; Strick CA; Williams VA; Zhang L
J Med Chem; 2009 Jun; 52(11):3576-85. PubMed ID: 19438227
[TBL] [Abstract][Full Text] [Related]
35. Targeting of NMDA receptors in new treatments for schizophrenia.
Hashimoto K
Expert Opin Ther Targets; 2014 Sep; 18(9):1049-63. PubMed ID: 24965576
[TBL] [Abstract][Full Text] [Related]
36. Spinal D-amino acid oxidase contributes to mechanical pain hypersensitivity induced by sleep deprivation in the rat.
Wei H; Gong N; Huang JL; Fan H; Ma AN; Li XY; Wang YX; Pertovaara A
Pharmacol Biochem Behav; 2013 Oct; 111():30-6. PubMed ID: 23958579
[TBL] [Abstract][Full Text] [Related]
37. Potential role for astroglial D-amino acid oxidase in extracellular D-serine metabolism and cytotoxicity.
Park HK; Shishido Y; Ichise-Shishido S; Kawazoe T; Ono K; Iwana S; Tomita Y; Yorita K; Sakai T; Fukui K
J Biochem; 2006 Feb; 139(2):295-304. PubMed ID: 16452318
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice.
Rais R; Thomas AG; Wozniak K; Wu Y; Jaaro-Peled H; Sawa A; Strick CA; Engle SJ; Brandon NJ; Rojas C; Slusher BS; Tsukamoto T
Drug Metab Dispos; 2012 Nov; 40(11):2067-73. PubMed ID: 22837388
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotic drug actions on gene modulation and signaling mechanisms.
Molteni R; Calabrese F; Racagni G; Fumagalli F; Riva MA
Pharmacol Ther; 2009 Oct; 124(1):74-85. PubMed ID: 19540875
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of D-amino acid oxidase activity by antipsychotic drugs evaluated by a fluorometric assay using D-kynurenine as substrate.
Iwasa S; Tabara H; Song Z; Nakabayashi M; Yokoyama Y; Fukushima T
Yakugaku Zasshi; 2011; 131(7):1111-6. PubMed ID: 21720142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
